1Koh JM, Kim ES, Ryu JS, et al. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study. Clin Endocrinol, 58:421-427.
2Pellegriti G, Scollo C, Regalbuto C. The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels. Clin Endocrinol, 58:556-561.
4Giammarile F, Hafdi Z, Bournaud C, et al. Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable r
5van Tol KM, Jager PL, de Vries EG, et al. Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin. Eur J Endocrinol, 2003,148:589-596.
6Frasoldati A, Pesenti M, Gallo M. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer, 2003,97:90-96.
7Torlontano M, Crocetti U, D′Aloiso L, et al. Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer. Eur J Endocrinol, 2003,148:19-24.
8el Hag IA, Chiedozi LC, al Reyees FA. Fine needle aspiration cytology of head and neck masses. Seven years′ experience in a secondary care hospital. Acta Cytol, 2003,47:387-392.
9Xing M, Usadel H, Cohen Y, et al. Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing. Cancer Res, 2003,63:2316-2321.
10Maruta J, Hashimoto H, Yamashita H, et al: Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma. Arch Surg. 2004,139:83-88.
3Us Krasovec M, Auersperg M, Bergant D, et al. Medullary carcinoma of the thyroid gland: diagnostic cytopathological characteristics [J].Pathologica, 1998, 90( 1):5.
4Orlandi F, Caraci E Mussa A, et al. Treatment of medullary thyroid carcinoma: an update [J]. Endocr Relat Cancer, 2001, 8(2):135-147.
